Idexx Laboratories (IDXX) Payables (2009 - 2026)

Idexx Laboratories' Payables history runs 18 years deep, the most recent figure standing at $130.0 million for Q1 2026.

• In Q1 2026, Payables rose 8.23% year-over-year to $130.0 million; the TTM figure through Mar 2026 stood at $130.0 million (up 8.23% YoY), while the FY2025 annual figure was $110.4 million, down 3.33% from the prior year.
• Payables was $130.0 million for Q1 2026 at Idexx Laboratories, up from $110.4 million in the prior quarter.
• In the past five years, Payables ranged from a high of $130.0 million in Q1 2026 to a low of $107.7 million in Q2 2023.
• Historically, Payables has averaged $116.2 million across 5 years, with a median of $116.6 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Payables jumped 38.66% in 2022, then slipped 15.4% in 2023.
• A 5-year view of Payables shows it stood at $110.2 million in 2022, then increased by 0.38% to $110.6 million in 2023, then rose by 3.22% to $114.2 million in 2024, then fell by 3.33% to $110.4 million in 2025, then advanced by 17.72% to $130.0 million in 2026.
• The last three Payables figures came in at $130.0 million (Q1 2026), $110.4 million (Q4 2025), and $122.3 million (Q3 2025), per Business Quant data.